acetyl-l-carnitine insulin resistance Muscle-Specific Deletion of Carnitine Acetyltransferase Compromises Glucose Tolerance and Metabolic Flexibility Frontiers | L–carnitine in metabolic

Reduced nicotinamide mononucleotide is a new and potent NAD+ precursor in mammalian cells and mice

WADA's rationale is that BPC-157 is a pharmacological substance not approved for human therapeutic use by any regulatory authority, and its tissue repair properties could provide a performance-enhancing benefit

Cells 46, 133141

In the eye, activation of M3 receptors causes contraction of the ciliary muscle, opening the trabecular meshwork and enhancing aqueous humor outflow, thereby reducing intraocular pressure

Developed at Monash University in Australia during the late 1990s, the peptide was engineered to isolate the lipolytic activity of growth hormone from its growth-promoting and diabetogenic effects